|
my friends and i were just talking about if there would ever be a cure for certain things. thats when they told me about an arcticle they had read in a magazine recently about dna research using alligator dna. i will post the arcticle here-
"There is a battle raging, a life-and-death struggle against an adaptive, elusive, unrelenting enemy. It’s not the war on terror. It is man against microbe in a world war where opportunistic invaders have been aided and abetted by careless overuse of antibiotics and one-time wonder drugs that have lost their potency against pathogens. It is a war against time. Today, science is desperately searching for new immunological approaches both in high-tech laboratories and exotic locales. New answers are sought in virgin rainforest and deep ocean swells, but it could be that the next big “secret weapon” in this war is lurking in the bayous of Southeast Texas and Louisiana. Alligators might make most people think of life-threatening injuries, but to biochemist Mark Merchant ’88, they could yield new ways of healing. Merchant has found that alligators— and their immune systems—could someday help us in our fight against infection. The grandson of a Cajun rice farmer, Merchant grew up hunting and fishing along the Louisiana and Southeast Texas coasts, and he has seen plenty of alligators. Now an associate professor of biochemistry at McNeese State University in Lake Charles, La., he has great admiration—and healthy respect—for these fiercely territorial reptiles. “They fight,” Merchant said. “They tear limbs off each other, and it’s very common for us to catch alligators that are missing limbs. Despite the fact that they live in this environment with all these microbes, they heal very rapidly and almost always without infection.” Virtually unchanged for more than 175 million years, the reptiles’ aggressive lifestyle puts a selective pressure on them. “You adapt, or you die. You either have to back off your lifestyle, or you adapt by developing some kind of immune system to fight the bacteria that you live around, because if you’re going to have a lot of these terrible wounds and be exposed to all the bacteria in the area, you’re going to need to have very good defense mechanisms.” “We think that part of that defense mechanism will be able to help us as humans and that modern molecular medicine should be able to benefit,” Merchant said. Powerful infection-fighting proteins—short chains of amino acids known as antibiotic peptides—could help fight against antibiotic-resistant bacteria. Active proteins extracted from alligators’ white blood cells have been found to kill a variety of bacteria and fungi. Merchant has shown that peptides can kill the herpes simplex virus, as well as fungal diseases and a broad range of bacteria, including MRSA (methicillin-resistant staphylococcus aureus) the lethal “super bug” that is becoming increasingly resistant to current antibiotics. He presented his findings at the annual meeting of the American Chemical Society. “We’re taking advantage of millions of years of Mother Nature’s product development. We do need a new class of drugs. That’s what is exciting—this wouldn’t just be a new drug but potentially a new class of drugs that work by a completely new class of mechanisms,” Merchant said. It may be difficult to meet the challenges of adapting peptides for clinical use, but, despite this, antibiotics containing alligator-blood-derived proteins could be on our shelves in 10 years, Merchant said.
Interest in immunology Researching alligators wasn’t Merchant’s focus, just one of several areas of interest when he first came to McNeese. But after fruitless Internet searching on the topic of alligators and infection, he soon realized that he had found an opportunity. “I kept thinking I wasn’t putting in the right research terms, but it became apparent that no one ever broached this issue.” “They always say in research that all the good ideas have already been taken,” Merchant said. “That’s not necessarily true. I landed on a gold mine. We started collecting publication-quality data from day one.” Today, Merchant’s discoveries have drawn an unprecedented international spotlight to the university and have resulted in scores of published papers, dozens of presentations and lots of media attention as well. As the knowledge base grows, Merchant’s research may yield “antibiotics that you take orally, but potentially also antibiotics that you could use topically on
wounds, such as diabetic ulcer wounds, burns and things like that. Be it topical or internal, we hope that we can isolate some protein that has antibiotic activity that would avert infection to give time to heal.” Merchant graduated from Nederland High School in 1984 and entered Lamar University pursuing a double major in biology and chemistry. He still lives in Nederland, where his wife, Jennifer (Cabra) ’88, who graduated Lamar with a degree in interior design, now teaches special-needs children in the Nederland and Port Neches school districts. The couple has a son, 17, and two daughters, 15 and 6. “When I started my senior year at Lamar, I didn’t have any aspirations of getting a Ph.D. That was an 11th-hour decision for me after prodding by some Lamar faculty who had encouraged me because I had shown a propensity for research.” Merchant enjoys keeping up with his LU professors—now colleagues in academe— and has high praise for them, but especially for the late Hugh Akers, who sparked his interest in biochemistry. “I worked in his lab as an undergraduate,” Merchant said. “I was going to go get a job at one of the plants, but Dr. Akers said, ‘Hey, you’ve really taken a shine to the research. Have you thought about going to grad school? Have you thought about going to med school? At least consider that.’” “And so I did. I couldn’t believe I was applying; I wasn’t ready for four more years of school. But it was the best decision I’ve ever made,” Merchant said. He attended graduate school at Texas A&M, graduating in 1992, and then spent three and a half years as a post-doctoral fellow at University of Texas Medical Branch in Galveston. “I sometimes joke that I’ve got a 100-mile rope around my neck,” Merchant said. At UTMB, Merchant studied heavymetal- induced stress genes. “My first loves
are molecular biology, genetic engineering and gene expression. We were looking at the molecular biochemical mechanisms of how genes are turned on and off inside our cells.” Merchant then came to Beaumont as a research and development lab manager for Helena Laboratories from 1996 to 2001 before the lure of research and teaching drew him to McNeese. There, he is passionate about his dual role, finding it so enjoyable he doesn’t consider it work. “I get to go into the lab and teach and do alligator research. That’s not work. I can teach students 10 times more in the lab than I can in the classroom,” Merchant said. “You can really see the light bulbs come on in the lab. That excites me to no end.” Eight undergraduates and two graduate students work with alligator- related projects in Merchant’s lab. “For several years, we looked at innate immunity and acquired immunity,” Merchant said. “Innate immunity is the branch of the immune system that does not require previous exposure. It is the first line of defense, always in a semi-active state ready to go to work. It is less specific in its target but more quick acting, designed to hold an infection at bay to allow acquired immunity opportunity to gear up.” Much of Merchant’s research is on blood drawn from populations, not from individual animals, typically pooling blood from 10 or 15 samples and taking averages. They have also looked for variations within a population, Merchant said. While a captive population of alligators is readily available across town, most collection from the wild is done in the summer or during winter breaks. One current study focuses on phospholipase A2, an enzyme providing innate immunity in alligators that is also present in humans. Interestingly, the enzyme isn’t found in newly hatched alligators, but, by one year of age, it is a part of their repertoire of resistance. Merchant, with his undergraduate and graduate assistants, is studying the development of the serumcomplement system using three groups of hatchlings under differing conditions. Thus far, they’ve found that slower-growing, outdoor- kept hatchlings develop the enzyme much faster, while their heat-lamp-hogging counterparts grow up to six times faster, but develop the immunity much later. A third group in the latest round of experiments has the addition of ultraviolet light. The results are pending. Merchant’s research interests are finding funding from a variety of sources, including the university and the National Science Foundation. A National Institutes of Health grant, with a co-investigator at LSU, is pending. In 2002, Merchant was introduced to the Crocodile Specialists Group, a worldwide research consortium concerned with crocodilian conservation, preservation, management and research. Since that time, he has been a frequent presenter at meetings around the world and has linked with colleagues in the U.S., Australia, France and Bolivia, setting up collaborative research with croc-expert Adam Britton of Big Gecko, a wildlife consultancy in Darwin, Australia, and caiman-experts Luciano Verdade and Pablo Siroski in Brazil and Argentina, respectively. In doing research in comparative biochemistry, Merchant is finding more similarities than differences between the species. In just three years, he has made presentations in 11 countries on four continents. Merchant enjoys sharing findings with “people who really care about this stuff, and that has opened up all these collaborations and sources of funding outside the country.” “You have a stark contrast in new modern molecular medicines and these ancient reptiles, a pretty interesting contrast,” Merchant said as he held a handful of squirming alligator hatchlings. “They may have something to offer us. Who knows?”
|